Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study Assessing the Effect of RO4607381 on Vascular Function in Patients With Coronary Heart Disease (CHD) or CHD-Risk Equivalent Patients

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Hoffmann-La Roche
ClinicalTrials.gov Identifier:
NCT00655538
First received: March 28, 2008
Last updated: November 1, 2016
Last verified: November 2016